Annual Working Capital
$333.75 M
-$93.68 M-21.92%
December 31, 2023
Summary
- As of February 7, 2025, BBIO annual working capital is $333.75 million, with the most recent change of -$93.68 million (-21.92%) on December 31, 2023.
- During the last 3 years, BBIO annual working capital has fallen by -$213.43 million (-39.01%).
- BBIO annual working capital is now -55.72% below its all-time high of $753.79 million, reached on December 31, 2021.
Performance
BBIO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$305.36 M
-$176.51 M-36.63%
September 30, 2024
Summary
- As of February 7, 2025, BBIO quarterly working capital is $305.36 million, with the most recent change of -$176.51 million (-36.63%) on September 30, 2024.
- Over the past year, BBIO quarterly working capital has dropped by -$28.39 million (-8.51%).
- BBIO quarterly working capital is now -64.49% below its all-time high of $860.04 million, reached on March 31, 2020.
Performance
BBIO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BBIO Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.9% | -8.5% |
| 3 y3 years | -39.0% | -8.5% |
| 5 y5 years | -19.1% | -8.5% |
BBIO Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.7% | at low | -59.5% | at low |
| 5 y | 5-year | -55.7% | at low | -64.5% | at low |
| alltime | all time | -55.7% | +276.8% | -64.5% | +13.9% |
BridgeBio Pharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $305.36 M(-36.6%) |
| Jun 2024 | - | $481.87 M(-24.9%) |
| Mar 2024 | - | $641.95 M(+92.3%) |
| Dec 2023 | $333.75 M(-21.9%) | $333.75 M(-30.7%) |
| Sep 2023 | - | $481.61 M(+49.2%) |
| Jun 2023 | - | $322.76 M(-29.2%) |
| Mar 2023 | - | $456.11 M(+6.7%) |
| Dec 2022 | $427.43 M(-43.3%) | $427.43 M(-18.3%) |
| Sep 2022 | - | $523.02 M(-17.0%) |
| Jun 2022 | - | $630.12 M(+2.8%) |
| Mar 2022 | - | $612.77 M(-18.7%) |
| Dec 2021 | $753.79 M | $753.79 M(+38.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $543.89 M(-30.1%) |
| Jun 2021 | - | $777.96 M(-8.5%) |
| Mar 2021 | - | $850.38 M(+55.4%) |
| Dec 2020 | $547.18 M(+7.7%) | $547.18 M(-18.3%) |
| Sep 2020 | - | $669.68 M(-12.9%) |
| Jun 2020 | - | $769.29 M(-10.6%) |
| Mar 2020 | - | $860.04 M(+69.2%) |
| Dec 2019 | $508.24 M(+23.2%) | $508.24 M(-1.9%) |
| Sep 2019 | - | $518.30 M(+93.4%) |
| Jun 2019 | - | $268.00 M(-22.8%) |
| Mar 2019 | - | $347.00 M(-15.9%) |
| Dec 2018 | $412.65 M(+365.8%) | $412.65 M |
| Dec 2017 | $88.58 M | - |
FAQ
- What is BridgeBio Pharma annual working capital?
- What is the all time high annual working capital for BridgeBio Pharma?
- What is BridgeBio Pharma annual working capital year-on-year change?
- What is BridgeBio Pharma quarterly working capital?
- What is the all time high quarterly working capital for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly working capital year-on-year change?
What is BridgeBio Pharma annual working capital?
The current annual working capital of BBIO is $333.75 M
What is the all time high annual working capital for BridgeBio Pharma?
BridgeBio Pharma all-time high annual working capital is $753.79 M
What is BridgeBio Pharma annual working capital year-on-year change?
Over the past year, BBIO annual working capital has changed by -$93.68 M (-21.92%)
What is BridgeBio Pharma quarterly working capital?
The current quarterly working capital of BBIO is $305.36 M
What is the all time high quarterly working capital for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly working capital is $860.04 M
What is BridgeBio Pharma quarterly working capital year-on-year change?
Over the past year, BBIO quarterly working capital has changed by -$28.39 M (-8.51%)